CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −35,829 | $312.17 | $11.2M | 15,706 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −14,915 | $313.19 | $4.7M | 791 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −740 | $314.32 | $233K | 51 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −51 | $315.06 | $16K | 0 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Option exercise · Share Option (Right to Buy) 10b5-1 | −840,164 | 441,870 | ||
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Option exercise 10b5-1 | +96,501 | $160.40 | $15.5M | 96,501 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Option exercise 10b5-1 | +70,096 | $119.96 | $8.4M | 166,597 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −233 | $311.98 | $73K | 166,364 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −4,881 | $314.08 | $1.5M | 161,483 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −9,516 | $314.73 | $3.0M | 151,967 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −19,752 | $316.00 | $6.2M | 132,215 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −32,224 | $316.82 | $10.2M | 99,991 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −42,798 | $317.79 | $13.6M | 57,193 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −6,402 | $318.55 | $2.0M | 50,791 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −15,097 | $319.99 | $4.8M | 35,694 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −20,505 | $321.00 | $6.6M | 15,189 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −13,109 | $321.61 | $4.2M | 2,080 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,560 | $322.71 | $503K | 520 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −520 | $323.59 | $168K | 0 |
| 2026-07-16 | OYLER JOHN Chief Executive Officer | Option exercise · Share Option (Right to Buy) 10b5-1 | −1,254,513 | 0 |
Page 7 of 71 · 1,406 trades